GNAI2 variants predict nonsteroidal anti‐inflammatory drug hypersensitivity in a genome‐wide study - Université de Lorraine
Article Dans Une Revue Allergy Année : 2019

GNAI2 variants predict nonsteroidal anti‐inflammatory drug hypersensitivity in a genome‐wide study

Résumé

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the drugs most frequently involved in drug hypersensitivity reactions through mechanisms that may involve genetic predisposition. We performed a fine-mapping GWAS in patients with NSAID-induced hypersen-sitivity reactions with cross-intolerance belonging to the group of NSAID-induced urticaria, angioedema, and anaphylaxis (NIUAA) (2) and matched controls from South Spain, and we replicated the re-sults in patients and paired controls from central Spain. GNAI2 was a significant predictor of NSAID-induced hypersensitivity reactions. This association may reflect its influence on the activation of leukot-riene receptors and the recruitment of immune cells involved in the pathological mechanisms of NSAID hypersensitivity.
Fichier non déposé

Dates et versions

hal-02504120 , version 1 (10-03-2020)

Identifiants

Citer

Miguel Blanca, Abderrahim Oussalah, José Antonio Cornejo‐garcía, Natalia Blanca‐lópez, Rosa-Maria Guéant-Rodriguez, et al.. GNAI2 variants predict nonsteroidal anti‐inflammatory drug hypersensitivity in a genome‐wide study. Allergy, 2019, 8 (2), pp.809-811. ⟨10.1111/all.14100⟩. ⟨hal-02504120⟩
63 Consultations
0 Téléchargements

Altmetric

Partager

More